NADIM II: Neo-Adjuvant Immunotherapy

Clinical trial NCT03838159 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03838159
Sponsor: Fundación GECP
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2019-05-15
Primary completion: 2027-11-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.